The problem: In today’s drug discovery environment, the difficulty is in identifying new treatments and technologies that are better and safer than the current standard of care.
We base our solutions on 3 pillars of excellence:
Safety, Originality & Quality
Safety begins with discovery. We leverage our years of expertise in numerous device driven and therapeutic areas such as cardiovascular, bone metabolism, cancer, diabetes, gastroenterology, gene-therapy, infectious disease, neurodegenerative disease, pain, psychiatric, respiratory and transplantation.
Originality is essential in today’s highly competitive life sciences industry. We help you evaluate the novelty of the discovery and estimate how the competition will respond. We look at current and upcoming research to determine the true impact of the discovery.
Quality is the backbone of every new discovery. We help you identify the scientific merits supporting each innovation.
We possess a highly qualified group of scientific experts who strive to identify new research targets that can help you develop and validate your product pipeline.
For companies wishing to acquire or merge, commercialize products, or invest in the life sciences sector, it is increasingly important to understand the science that underpins a new medication or technology. A detailed scientific analysis will guarantee that an organization is able to continue to develop and innovate in new areas.